9966•Hong Kong Stock Exchange•Healthcare•Hong Kong•$11.21B

Stocks Similar to 9966

Top 20 stocks similar to Alphamab Oncology based on sector, industry, market cap, and valuation multiples. Same-industry peers (Biotechnology) are ranked first.

Company	Industry	Market Cap	P/E	Yield	Change	Compare
BM Biomarin Pharmaceutical Inc BMRN • United States	Biotechnology	$11.25B	32.5	—	+0.20%	vs
EX Exelixis Inc EXEL • United States	Biotechnology	$11.01B	14.8	—	+1.40%	vs
TU Tubize-Fin TUB • Belgium	Biotechnology	$11.98B	108.7	0.49%	+0.97%	vs
68 RemeGen Co. Ltd. A 688331 • China	Biotechnology	$12.23B	114.8	—	+10.80%	vs
01 SAMSUNG EPISHOLDINGS CO LTD 0126Z0 • South Korea	Biotechnology	$10.25B	0.0	—	+8.04%	vs
AB Abivax SA ABVX • France	Biotechnology	$9.79B	0.0	—	-2.97%	vs
Akeso, Inc. AKESF • United States	Biotechnology	$13.13B	0.0	—	+9.85%	vs
ABIVAX Société Anonyme AAVXF • United States	Biotechnology	$9.56B	0.0	—	+0.00%	vs
BB BridgeBio Pharma Inc BBIO • United States	Biotechnology	$13.46B	0.0	—	+2.90%	vs
00 Xizang Haisco Pharmaceutical Group Co Ltd 002653 • China	Biotechnology	$9.20B	243.6	0.47%	-0.18%	vs
AS Ascendis Pharma AS ASND • United States	Biotechnology	$13.87B	0.0	—	+2.17%	vs
Sino Biopharmaceutical Ltd 1177 • Hong Kong	Biotechnology	$13.88B	40.5	1.54%	+1.35%	vs
SB Sino Biopharmaceutical Limited SBMFF • United States	Biotechnology	$13.91B	25.9	155.00%	+0.13%	vs
99 Remegen Co Ltd 9995 • Hong Kong	Biotechnology	$8.25B	73.2	—	+13.11%	vs
AB Abivax SA American Depositary Shares ABVX • United States	Biotechnology	$8.19B	0.0	—	-4.74%	vs
Pharmaron Beijing Co Ltd 300759 • China	Biotechnology	$8.15B	32.2	0.64%	-2.06%	vs
69 Sichuan Kelun-Biotech 6990 • Hong Kong	Biotechnology	$15.42B	0.0	—	+5.48%	vs
AR Arrowhead Pharmaceuticals Inc ARWR • United States	Biotechnology	$8.03B	35.9	—	+6.71%	vs
AX Axsome Therapeutics Inc AXSM • United States	Biotechnology	$7.98B	0.0	—	+6.11%	vs
68 InnoCare Pharma Ltd. A 688428 • China	Biotechnology	$7.90B	80.5	—	+6.61%	vs

How we rank similar stocks

Similarity is scored by sector match (baseline), industry match (priority boost), log-scale market cap proximity, and valuation multiple closeness (P/E and dividend yield). Same-industry peers surface first, then nearest-size same-sector peers.

View all Healthcare stocks →